Guanhao Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	144.22	160.6	106.78	105.14	126.28	159.31
Cash & Short-Term Investments	144.22	160.6	106.78	105.14	126.28	159.31
Cash Growth	18.36%	50.41%	1.56%	-16.74%	-20.73%	1.99%
Accounts Receivable	61.06	52.45	59.55	61.14	71.98	106.71
Other Receivables	1.91	2.96	2.21	13.36	8.74	11.04
Receivables	62.98	55.42	61.75	74.51	80.72	117.75
Inventory	71	77.71	78.46	71.6	61.68	140.55
Prepaid Expenses	-	0.43	-	-	-	-
Other Current Assets	29.64	31.45	18.8	16.03	30.22	17.81
Total Current Assets	307.84	325.61	265.79	267.28	298.89	435.41
Property, Plant & Equipment	331.95	332.47	332.47	252.04	214.6	245.54
Long-Term Investments	15	15.19	22.49	32.08	32.56	74.22
Goodwill	-	-	-	-	-	214.33
Other Intangible Assets	70.6	71.81	72.7	78.66	87.49	64.14
Long-Term Deferred Tax Assets	17.68	17.66	18.42	14.97	13.16	41.44
Long-Term Deferred Charges	34.87	33.87	29.88	24.17	23.58	23.66
Other Long-Term Assets	9.29	9.92	12.65	9.41	-	-
Total Assets	787.22	806.53	754.4	678.59	670.27	1,099
Accounts Payable	13.98	20.13	35.65	29.32	2.16	1.88
Accrued Expenses	12.42	65.05	59.45	58.01	52.96	83
Short-Term Debt	14.99	15	20.01	24.52	49.05	51.56
Current Portion of Long-Term Debt	-	2.22	0.09	-	-	54.69
Current Portion of Leases	-	3.96	5.64	6.07	7.49	9.51
Current Income Taxes Payable	2.01	3.4	4.71	3.96	13.72	14.62
Current Unearned Revenue	36.57	31.71	28.76	21.97	28.29	17.1
Other Current Liabilities	73.63	47.06	23.69	28.86	35.32	29.91
Total Current Liabilities	153.6	188.54	177.99	172.72	188.99	262.27
Long-Term Debt	113.24	103.89	76	12.02	-	-
Long-Term Leases	1.35	1.85	6.62	12.06	22.52	35.62
Long-Term Unearned Revenue	17.91	18.21	19.43	20.65	22.85	40.94
Long-Term Deferred Tax Liabilities	5.41	5.42	6.77	4.9	4.97	11.74
Other Long-Term Liabilities	0.8	0.8	-	-	-	-
Total Liabilities	292.32	318.72	286.81	222.33	239.33	350.58
Common Stock	265.16	265.16	265.16	265.16	265.16	265.16
Additional Paid-In Capital	598.03	598.03	594.54	600.27	600.27	597.71
Retained Earnings	-236.44	-246.6	-270.95	-298.37	-329.37	-21.57
Comprehensive Income & Other	-46.63	-46.51	-46.39	-46.46	-50.71	-57.38
Total Common Equity	580.12	570.07	542.36	520.59	485.34	783.92
Minority Interest	-85.21	-82.25	-74.77	-64.33	-54.4	-35.76
Shareholders' Equity	494.91	487.82	467.59	456.26	430.94	748.16
Total Liabilities & Equity	787.22	806.53	754.4	678.59	670.27	1,099
Total Debt	129.59	126.93	108.35	54.67	79.06	151.38
Net Cash (Debt)	14.64	33.68	-1.57	50.47	47.22	7.93
Net Cash Growth	-	-	-	6.88%	495.52%	-
Net Cash Per Share	0.05	0.12	-0.01	0.20	0.18	0.03
Filing Date Shares Outstanding	254.06	265.16	265.16	265.16	265.16	265.16
Total Common Shares Outstanding	254.06	265.16	265.16	265.16	265.16	265.16
Working Capital	154.24	137.07	87.8	94.56	109.9	173.14
Book Value Per Share	2.28	2.15	2.05	1.96	1.83	2.96
Tangible Book Value	509.52	498.25	469.66	441.93	397.85	505.45
Tangible Book Value Per Share	2.01	1.88	1.77	1.67	1.50	1.91
Buildings	-	392.94	392.83	225.53	239.59	239.59
Machinery	-	99.79	99.41	99.17	101.29	106.02
Construction In Progress	-	18.03	2.54	73.99	2.8	2.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.